Prolonged Survival of a Patient With Metastatic Leptomeningeal Melanoma Treated With BRAF Inhibition-Based Therapy: A Case Report

BMC Cancer - United Kingdom
doi 10.1186/s12885-015-1391-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Increased Survival Time of a Patient With Metastatic Malignant Melanoma Following Immunotherapy: A Case Report and Literature Review

Oncology Letters
Cancer ResearchOncology
2015English

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

JAMA Oncology
Cancer ResearchOncology
2019English

Metastatic Amelanotic Melanoma With Cardiac Involvement: A Case Report

Journal of Cardiology Cases
Cardiovascular MedicineCardiology
2019English

Perirenal Hematoma in a Patient Treated With Bevacizumab for Metastatic Colon Cancer: A Case Report

Oncology Letters
Cancer ResearchOncology
2016English

Long-Term Survival in a Patient With Metastatic Squamous Cell Lung Carcinoma: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Inoculation Site From a Cutaneous Melanoma Patient Treated With an Allogeneic Therapeutic Vaccine: A Case Report

Frontiers in Immunology
AllergyImmunology
2015English

Extrapolating Survival in a Heterogeneous Patient Population With Metastatic Melanoma; A Case Study of Integrating Statistical and Clinical Consideration

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab

Journal of Cutaneous Immunology and Allergy
2019English

Scalp Melanoma Treated With Ipilimumab in Elderly Patient: A Complete Response to Treatment—Case Report

Journal of Pharmacy and Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy